Article History
Received: 15 March 2022
Accepted: 13 April 2022
First Online: 23 May 2022
Declarations
:
: OA: advisory boards with Roche, Eisai, Lilly, Ipsen, Amgen, and Bayer. SG: none, DM: none.
: This work was approved by the Health Research Ethics Board of Alberta (HREBA.CC-20-0217). Given the retrospective nature of data collection.
: Informed consent was waived by the ethics committee.